Roivant Sciences Ltd., 10% Owner at Myovant Sciences Ltd. (MYOV), bought 179,193 shares at $18.21 ($3.3M) on 2019-12-02, disclosed to the SEC on 2019-12-04.
Open-market purchase of $3.3M MYOV by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.21 | 113,668 | $2.1M | 62.6% |
| 2 | $18.85 | 65,525 | $1.2M | 37.4% |
| Total | $18.44 avg | 179,193 | $3.3M | 100% |
| Filing → |
| IMVT | BUY | 2023-10-04 | $58.0M | — | Filing → |
| IMVT | BUY | 2022-10-07 | $2.5M | — | Filing → |
| IMVT | BUY | 2020-09-04 | $12.5M | — | Filing → |